Footnotes

2. The Cardiovascular System

1.   H. P. Ammon and M. Handel, “Crataegus, Toxicology and Pharmacy, Part I; Toxicity” [author’s translation], Planta Medica 43/2 (Oct. 1981): 105–20.

5. The Nervous System

1.   F. Clostre, “From the body to the cell membrane: the different levels of pharmacological action of Ginkgo biloba extract,” Presse Med 15/3, no. 1 (Sept. 25, 1986): 1529–38.

2.   Gautherie et al., “Vasodilator effect of Gingko biloba extract determined by skin thermometry and thermography,” Therapie 27/5 (Sept.-Oct. 72): 881–92.

3.   D. M. Warburton, “Clinical psychopharmacology of Ginkgo biloba extract,” Presse Med 15/31 (Sept. 25, 1986): 1595–604.

4.   M. Allard, “Treatment of the disorders of aging with Ginkgo biloba extract: From pharmacology to clinical medicine,” Presse Med 15/31 (Sept. 25, 1986): 1540–45.

5.   Fünfgeld, E. W. (ed.). Rökan, Ginkgo biloba. Recent Results in Pharmacology and Clinic (Berlin: Springer-Verlag, 1988).

6.   Stange et al., “Adaptational behaviour of peripheral and central acoustic responses in guinea pigs under the influence of various fractions of an extract from Ginkgo biloba,” Arzneim Forsch 26/3 (1976): 367–74.